XML 147 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Tungsten [Member]
Common Stock [Member]
Tungsten [Member]
Additional Paid-in Capital [Member]
Tungsten [Member]
Retained Earnings [Member]
Tungsten [Member]
AOCI Attributable to Parent [Member]
Tungsten [Member]
Parent [Member]
Tungsten [Member]
Noncontrolling Interest [Member]
Tungsten [Member]
Cross Currency Interest Rate Contract [Member]
Common Stock [Member]
Cross Currency Interest Rate Contract [Member]
Additional Paid-in Capital [Member]
Cross Currency Interest Rate Contract [Member]
Retained Earnings [Member]
Cross Currency Interest Rate Contract [Member]
AOCI Attributable to Parent [Member]
Cross Currency Interest Rate Contract [Member]
Parent [Member]
Cross Currency Interest Rate Contract [Member]
Noncontrolling Interest [Member]
Cross Currency Interest Rate Contract [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Parent [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2018                                                         50,700            
Balance in Other comprehensive income (loss) beginning of period at Dec. 31, 2018                                                         $ 51 $ 901,363 $ 422,164 $ (3,799) $ 1,319,779 $ 125,259 $ 1,445,038
Stock-based compensation                                                         $ 0 9,358 0 0 9,358 0 9,358
Exercise of options by employees and directors (*) (in shares)                                                         332            
Exercise of options by employees and directors (*) [1]                                                         $ 0 2,429 0 0 2,429 0 2,429
Cash paid to noncontrolling interest                                                         0 0 0 0 0 (8,329) (8,329)
Cash dividend declared                                                         0 0 (22,386) 0 (22,386) 0 (22,386)
Increase in noncontrolling interest $ 0 $ 0 $ 0 $ 0 $ 0 $ 2,072 $ 2,072                                                        
Purchase of U.S. Geothermal                                                         0 0 0 0 0 0 0
Net income                                                         0 0 88,095 0 88,095 4,316 92,411
Foreign currency translation adjustments                                                         0 0 0 (1,482) (1,482) (328) (1,810)
Change in respect of derivative instruments designated for cash flow hedge               $ 0 $ 0 $ 0 $ 75 $ 75 $ 0 $ 75                                          
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment                                                         0 0 0 (3,417) (3,417) 0 (3,417)
Amortization of unrealized gains in respect of derivative instruments designated for cash flow hedge                                                         $ 0 0 0 (31) (31) 0 (31)
Other                                                                     44
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                                                                     0
Balance (in shares) at Dec. 31, 2019                                           51,032             51,032            
Balance in Other comprehensive income (loss) end of period at Dec. 31, 2019                             $ 0 $ 0 $ (755) $ 0 $ (755) $ 0 $ (755) $ 51 $ 913,150 $ 487,118 $ (8,654) $ 1,391,665 $ 122,990 $ 1,514,655 $ 51 913,150 487,873 (8,654) 1,392,420 122,990 1,515,410
Stock-based compensation                                                         $ 0 9,830 0 0 9,830 0 9,830
Exercise of options by employees and directors (*) (in shares)                                                         178            
Exercise of options by employees and directors (*) [1]                                                         $ 0 0 0 0 0 0 0
Cash paid to noncontrolling interest                                                         0 0 0 0 0 (6,756) (6,756)
Cash dividend declared                                                         0 0 (22,471) 0 (22,471) 0 (22,471)
Increase in noncontrolling interest                                                         0 0 0 0 0 2,754 2,754
Net income                                                         0 0 85,456 0 85,456 15,020 100,476
Foreign currency translation adjustments                                                         0 0 0 2,369 2,369 1,444 3,813
Change in respect of derivative instruments designated for cash flow hedge               0 0 0 3,366 3,366 0 3,366                                          
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment                                                         $ 0 0 0 (3,975) (3,975) 0 (3,975)
Common stock issuance (in shares)                                                         4,773            
Common stock issuance                                                         $ 5 339,466 0 0 339,471 0 339,471
Other                                                         $ 0 0 0 274 274 0 274
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                                                                     0
Balance (in shares) at Dec. 31, 2020                                                         55,983            
Balance in Other comprehensive income (loss) end of period at Dec. 31, 2020                                                         $ 56 1,262,446 550,103 (6,620) 1,805,985 135,452 1,941,437
Stock-based compensation                                                         $ 0 9,168 0 0 9,168 0 9,168
Exercise of options by employees and directors (*) (in shares)                                                         73            
Exercise of options by employees and directors (*) [1]                                                         $ 0 0 0 0 0 0 0
Cash paid to noncontrolling interest                                                         0 0 0 0 0 (5,507) (5,507)
Cash dividend declared                                                         0 0 (26,986) 0 (26,986) 0 (26,986)
Increase in noncontrolling interest                                                         0 0 0 0 0 1,357 1,357
Net income                                                         0 0 62,092 0 62,092 13,366 75,458
Foreign currency translation adjustments                                                         0 0 0 (2,030) (2,030) (1,206) (3,236)
Change in respect of derivative instruments designated for cash flow hedge               $ 0 $ 0 $ 0 $ 2,379 $ 2,379 $ 0 $ 2,379                                          
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment                                                         0 0 0 3,892 3,892 0 3,892
Other                                                         0 0 0 228 228 0 228
Stock issuance costs reimbursement                                                         0 311 0 0 311 0 311
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                                                         $ 0 0 0 (40) (40) 0 (40)
Balance (in shares) at Dec. 31, 2021                                                         56,056            
Balance in Other comprehensive income (loss) end of period at Dec. 31, 2021                                                         $ 56 $ 1,271,925 $ 585,209 $ (2,191) $ 1,854,999 $ 143,462 $ 1,998,461
[1] Resulted in an amount lower than $1 thousand.